array:34 [ "id" => array:1 [ 0 => array:1 [ "value" => "5270" ] ] "isin" => array:1 [ 0 => array:1 [ "value" => "DE000LS9FPW6" ] ] "wkn" => array:1 [ 0 => array:1 [ "value" => "LS9FPW" ] ] "name" => array:1 [ 0 => array:1 [ "value" => "BIPHAGE" ] ] "short_description" => array:1 [ 0 => array:1 [ "value" => "Biotech, Pharmazie und Generika " ] ] "long_description" => array:1 [ 0 => array:1 [ "value" => """ Ziel dieses Portfolios ist es hauptsächlich in wachstumsstarke Unternehmen aus dem Biotechnologie- und Generikasektor zu investieren. \r\n Bei der Aktienauswahl sollen sowohl die fundamentalen Zahlen und Jahresberichte, als auch die Produktpalette und Pipeline untersucht werden. Investments sollen hauptsächlich in Aktien erfolgen. Falls sich jedoch zeitweilig keine interessanten Werte finden kann auch in Fonds oder ETF's der Biotechbranche, oder bei stark fallenden Märkten Short-ETF's auf Indizes investiert werden.\r\n Im Schnitt sollen etwa 10-20 Titel gehalten werden. \r\n \r\n """ ] ] "status" => array:1 [ 0 => array:1 [ "value" => "Investable" ] ] "trader_name" => array:1 [ 0 => array:1 [ "value" => "Enigma" ] ] "symbol" => array:1 [ 0 => array:1 [ "value" => "WF0BIPHAGE" ] ] "creation_date" => array:1 [ 0 => array:1 [ "value" => "1418319511" ] ] "issuing_date" => array:1 [ 0 => array:1 [ "value" => "1431912695" ] ] "daily_free_relative" => array:1 [ 0 => array:1 [ "value" => "0.95" ] ] "performance_free_relative" => array:1 [ 0 => array:1 [ "value" => "10" ] ] "cash" => array:1 [ 0 => array:1 [ "value" => "23517.6" ] ] "url" => array:1 [ 0 => array:1 [ "value" => "https://www.wikifolio.com/de/ch/w/wf0biphage" ] ] "href" => array:1 [ 0 => array:1 [ "value" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9fpw6" ] ] "wikifolio_tags" => array:1 [ 0 => array:1 [ "value" => "a:12:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:11:"fundamental";s:16:"ShortDescription";s:20:"Fundamentale Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:3;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:4;a:3:{s:4:"Name";s:6:"divers";s:16:"ShortDescription";s:20:"Aktiv diversifiziert";s:8:"TagGroup";s:11:"Handelsstil";}i:5;a:3:{s:4:"Name";s:10:"schwer-usa";s:16:"ShortDescription";s:15:"Schwerpunkt USA";s:8:"TagGroup";s:35:"ExtendedSearchInvestmentRegionGroup";}i:6;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:7;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:8;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:9;a:3:{s:4:"Name";s:5:"fonds";s:16:"ShortDescription";s:5:"Fonds";s:8:"TagGroup";s:15:"Anlageuniversum";}i:10;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:11;a:3:{s:4:"Name";s:8:"techanal";s:16:"ShortDescription";s:18:"Technische Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}}" ] ] "rankings" => array:1 [ 0 => array:1 [ "value" => "a:8:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:1439.408063;s:5:"Index";i:3563;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:6.523800710688;s:5:"Index";i:8333;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:0;s:5:"Index";i:26818;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:7.149930819;s:5:"Index";i:25356;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:-28.029596861796;s:5:"Index";i:87734;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:1.077022507;s:5:"Index";i:31569;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:-1.640372871;s:5:"Index";i:49338;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-53.7116300009;s:5:"Index";i:81930;}}" ] ] "wikifolio_items" => array:1 [ 0 => array:1 [ "value" => "a:36:{i:0;a:8:{s:4:"ISIN";s:12:"DK0010272202";s:3:"WKN";s:6:"565131";s:16:"ShortDescription";s:6:"GENMAB";s:13:"AbsoluteValue";d:4354;s:13:"RelativeValue";d:0.1851380104081509;s:12:"AbsoluteGain";d:1094.16666666666;s:12:"RelativeGain";d:0.3356511069073034;s:8:"Quantity";d:20;}i:1;a:8:{s:4:"ISIN";s:12:"IE00B4Q5ZN47";s:3:"WKN";s:6:"A1JS1K";s:16:"ShortDescription";s:25:"JAZZ PHARMACEUT. DL-,0001";s:13:"AbsoluteValue";d:195.2;s:13:"RelativeValue";d:0.008300169874063174;s:12:"AbsoluteGain";d:57.507;s:12:"RelativeGain";d:0.4176465034533346;s:8:"Quantity";d:1;}i:2;a:8:{s:4:"ISIN";s:12:"SE0000872095";s:3:"WKN";s:6:"A0LA5K";s:16:"ShortDescription";s:24:"SWEDISH ORPHAN BIOVITRUM";s:13:"AbsoluteValue";d:39.84;s:13:"RelativeValue";d:0.0016940510644604346;s:12:"AbsoluteGain";d:22.048;s:12:"RelativeGain";d:1.2392086330935252;s:8:"Quantity";d:1;}i:3;a:8:{s:4:"ISIN";s:12:"CH0334081137";s:3:"WKN";s:6:"A2AT0Z";s:16:"ShortDescription";s:25:"CRISPR THERAPEUT. SF -,03";s:13:"AbsoluteValue";d:2785.8;s:13:"RelativeValue";d:0.11845601042605117;s:12:"AbsoluteGain";d:555.68342800782;s:12:"RelativeGain";d:0.2491723683804671;s:8:"Quantity";d:60;}i:4;a:8:{s:4:"ISIN";s:12:"CNE100000FN7";s:3:"WKN";s:6:"A0N99U";s:16:"ShortDescription";s:30:"SINOPHARM MEDICINE HOLDING CO.";s:13:"AbsoluteValue";d:1.84;s:13:"RelativeValue";d:7.823930618993974E-5;s:12:"AbsoluteGain";d:-2.302703773163;s:12:"RelativeGain";d:-0.5558456262502351;s:8:"Quantity";d:1;}i:5;a:8:{s:4:"ISIN";s:12:"BE0003818359";s:3:"WKN";s:6:"A0EAT9";s:16:"ShortDescription";s:25:"LAKEFRONT BIOTHERAPEUTICS";s:13:"AbsoluteValue";d:24.5;s:13:"RelativeValue";d:0.0010417733704638716;s:12:"AbsoluteGain";d:-61.816741545894;s:12:"RelativeGain";d:-0.716161667351941;s:8:"Quantity";d:1;}i:6;a:8:{s:4:"ISIN";s:12:"CA1380357048";s:3:"WKN";s:6:"A3E2FV";s:16:"ShortDescription";s:13:"CANOPY GROWTH";s:13:"AbsoluteValue";d:0.0826;s:13:"RelativeValue";d:3.5122645061353385E-6;s:12:"AbsoluteGain";d:-24.420311561915;s:12:"RelativeGain";d:-0.996628972039046;s:8:"Quantity";d:0.1;}i:7;a:8:{s:4:"ISIN";s:12:"CA05335P1099";s:3:"WKN";s:6:"A2JNSX";s:16:"ShortDescription";s:18:"AUXLY CANNABIS GRP";s:13:"AbsoluteValue";d:0.1132;s:13:"RelativeValue";d:4.813418185163685E-6;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:1;}i:8;a:8:{s:4:"ISIN";s:12:"DE000A4BGGM7";s:3:"WKN";s:6:"A4BGGM";s:16:"ShortDescription";s:25:"BIOFRONTERA AG NA ON KONV";s:13:"AbsoluteValue";d:59.06952;s:13:"RelativeValue";d:0.0025117164466156357;s:12:"AbsoluteGain";d:-3086.430480000001;s:12:"RelativeGain";d:-0.9812209442060086;s:8:"Quantity";d:25.461;}i:9;a:8:{s:4:"ISIN";s:12:"DE000A1MMCC8";s:3:"WKN";s:6:"A1MMCC";s:16:"ShortDescription";s:15:"MEDIOS AG O.N.";s:13:"AbsoluteValue";d:12.6;s:13:"RelativeValue";d:0.0005357691619528482;s:12:"AbsoluteGain";d:-8.49;s:12:"RelativeGain";d:-0.40256045519203415;s:8:"Quantity";d:1;}i:10;a:8:{s:4:"ISIN";s:12:"DE000A1EWVY8";s:3:"WKN";s:6:"A1EWVY";s:16:"ShortDescription";s:11:"FORMYCON AG";s:13:"AbsoluteValue";d:19.5;s:13:"RelativeValue";d:0.0008291665601651223;s:12:"AbsoluteGain";d:-16.5;s:12:"RelativeGain";d:-0.4583333333333333;s:8:"Quantity";d:1;}i:11;a:8:{s:4:"ISIN";s:12:"US8006771062";s:3:"WKN";s:6:"936386";s:16:"ShortDescription";s:25:"SANGAMO THERAP.INC.DL-,01";s:13:"AbsoluteValue";N;s:13:"RelativeValue";N;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:500;}i:12;a:8:{s:4:"ISIN";s:12:"US8101861065";s:3:"WKN";s:6:"883369";s:16:"ShortDescription";s:25:"SCOTTS MIRAC.GRO A DL-,01";s:13:"AbsoluteValue";d:56.14;s:13:"RelativeValue";d:0.002387149266034357;s:12:"AbsoluteGain";d:-34.716;s:12:"RelativeGain";d:-0.3820991459012063;s:8:"Quantity";d:1;}i:13;a:8:{s:4:"ISIN";s:12:"US75886F1075";s:3:"WKN";s:6:"881535";s:16:"ShortDescription";s:25:"REGENERON PHARMAC.DL-,001";s:13:"AbsoluteValue";d:2644.5;s:13:"RelativeValue";d:0.11244774196700852;s:12:"AbsoluteGain";d:1048.98947368421;s:12:"RelativeGain";d:0.6574632109174752;s:8:"Quantity";d:5;}i:14;a:8:{s:4:"ISIN";s:12:"US7599161095";s:3:"WKN";s:6:"870980";s:16:"ShortDescription";s:25:"REPLIGEN CORP. DL-,01";s:13:"AbsoluteValue";d:6882;s:13:"RelativeValue";d:0.29263201369519853;s:12:"AbsoluteGain";d:2262;s:12:"RelativeGain";d:0.4896103896103896;s:8:"Quantity";d:60;}i:15;a:8:{s:4:"ISIN";s:12:"US74834L1008";s:3:"WKN";s:6:"904533";s:16:"ShortDescription";s:25:"QUEST DIAGNOSTICS DL-,01";s:13:"AbsoluteValue";d:169.5;s:13:"RelativeValue";d:0.007207370869127602;s:12:"AbsoluteGain";d:105.68;s:12:"RelativeGain";d:1.655907239109997;s:8:"Quantity";d:1;}i:16;a:8:{s:4:"ISIN";s:12:"US91324P1021";s:3:"WKN";s:6:"869561";s:16:"ShortDescription";s:25:"UNITEDHEALTH GROUP DL-,01";s:13:"AbsoluteValue";d:348.6;s:13:"RelativeValue";d:0.014822946814028803;s:12:"AbsoluteGain";d:243.166666666667;s:12:"RelativeGain";d:2.306354726525461;s:8:"Quantity";d:1;}i:17;a:8:{s:4:"ISIN";s:12:"US92532F1003";s:3:"WKN";s:6:"882807";s:16:"ShortDescription";s:25:"VERTEX PHARMAC. DL-,01";s:13:"AbsoluteValue";d:3913.5;s:13:"RelativeValue";d:0.1664073504208311;s:12:"AbsoluteGain";d:2687.06130058757;s:12:"RelativeGain";d:2.1909462754843796;s:8:"Quantity";d:10;}i:18;a:8:{s:4:"ISIN";s:12:"US28106W1036";s:3:"WKN";s:6:"A2AC4K";s:16:"ShortDescription";s:25:"EDITAS MEDICINE DL-,0001";s:13:"AbsoluteValue";d:2.33;s:13:"RelativeValue";d:9.907477359921718E-5;s:12:"AbsoluteGain";d:-25.948;s:12:"RelativeGain";d:-0.9176037909328807;s:8:"Quantity";d:1;}i:19;a:8:{s:4:"ISIN";s:12:"US2183521028";s:3:"WKN";s:6:"529882";s:16:"ShortDescription";s:25:"CORCEPT THERAPEUTICS INC.";s:13:"AbsoluteValue";d:69.36;s:13:"RelativeValue";d:0.0029492816724642503;s:12:"AbsoluteGain";d:55.591484131966;s:12:"RelativeGain";d:4.0375799879078675;s:8:"Quantity";d:1;}i:20;a:8:{s:4:"ISIN";s:12:"US29089Q1058";s:3:"WKN";s:6:"A0LC2W";s:16:"ShortDescription";s:25:"EMERGENT BIOSOLNS DL-,001";s:13:"AbsoluteValue";d:762.3;s:13:"RelativeValue";d:0.03241403429814732;s:12:"AbsoluteGain";d:-4646.77499999999;s:12:"RelativeGain";d:-0.8590701737358049;s:8:"Quantity";d:110;}i:21;a:8:{s:4:"ISIN";s:12:"US30161Q1040";s:3:"WKN";s:6:"936718";s:16:"ShortDescription";s:25:"EXELIXIS INC. DL-,01";s:13:"AbsoluteValue";d:4576;s:13:"RelativeValue";d:0.19457775278541536;s:12:"AbsoluteGain";d:2998;s:12:"RelativeGain";d:1.899873257287706;s:8:"Quantity";d:100;}i:22;a:8:{s:4:"ISIN";s:12:"US31572Q8814";s:3:"WKN";s:6:"A419WK";s:16:"ShortDescription";s:25:"KYNTRA BIO INC. NEW O.N.";s:13:"AbsoluteValue";d:0.232;s:13:"RelativeValue";d:9.864955997861968E-6;s:12:"AbsoluteGain";d:-42.049947712418;s:12:"RelativeGain";d:-0.9945130247646595;s:8:"Quantity";d:0.04;}i:23;a:8:{s:4:"ISIN";s:12:"US4523271090";s:3:"WKN";s:6:"927079";s:16:"ShortDescription";s:25:"ILLUMINA INC. DL-,01";s:13:"AbsoluteValue";d:1406.8;s:13:"RelativeValue";d:0.05981905214565611;s:12:"AbsoluteGain";d:-225.5192;s:12:"RelativeGain";d:-0.13815876208525882;s:8:"Quantity";d:10;}i:24;a:8:{s:4:"ISIN";s:12:"US4622601007";s:3:"WKN";s:6:"A2DT49";s:16:"ShortDescription";s:25:"IOVANCE BIOTHERAP.DL-,001";s:13:"AbsoluteValue";d:667;s:13:"RelativeValue";d:0.02836174849385316;s:12:"AbsoluteGain";d:-3187;s:12:"RelativeGain";d:-0.8269330565646082;s:8:"Quantity";d:200;}i:25;a:8:{s:4:"ISIN";s:12:"US53220K5048";s:3:"WKN";s:6:"A1C9RN";s:16:"ShortDescription";s:27:"LIGAND PHARMACEUTICALS INC.";s:13:"AbsoluteValue";d:1190;s:13:"RelativeValue";d:0.050600420851102335;s:12:"AbsoluteGain";d:621.977916666665;s:12:"RelativeGain";d:1.0949889712327732;s:8:"Quantity";d:5;}i:26;a:8:{s:4:"ISIN";s:12:"US60770K1079";s:3:"WKN";s:6:"A2N9D9";s:16:"ShortDescription";s:25:"MODERNA INC. DL-,0001";s:13:"AbsoluteValue";d:2214;s:13:"RelativeValue";d:0.0941422956002862;s:12:"AbsoluteGain";d:-518.4;s:12:"RelativeGain";d:-0.18972332015810275;s:8:"Quantity";d:40;}i:27;a:8:{s:4:"ISIN";s:12:"US58155Q1031";s:3:"WKN";s:6:"893953";s:16:"ShortDescription";s:25:"MCKESSON DL-,01";s:13:"AbsoluteValue";d:647.4;s:13:"RelativeValue";d:0.02752832979748206;s:12:"AbsoluteGain";d:468.303;s:12:"RelativeGain";d:2.614800917938324;s:8:"Quantity";d:1;}i:28;a:8:{s:4:"ISIN";s:12:"US64125C1099";s:3:"WKN";s:6:"900964";s:16:"ShortDescription";s:27:"NEUROCRINE BIOSCIENCES INC.";s:13:"AbsoluteValue";d:6875;s:13:"RelativeValue";d:0.2923343641607803;s:12:"AbsoluteGain";d:2985;s:12:"RelativeGain";d:0.7673521850899743;s:8:"Quantity";d:50;}i:29;a:8:{s:4:"ISIN";s:12:"US07725L1026";s:3:"WKN";s:6:"A1437N";s:16:"ShortDescription";s:18:"BEIGENE LTD SP.ADR";s:13:"AbsoluteValue";d:236;s:13:"RelativeValue";d:0.010035041446100968;s:12:"AbsoluteGain";d:134.299;s:12:"RelativeGain";d:1.3205278217519985;s:8:"Quantity";d:1;}i:30;a:8:{s:4:"ISIN";s:12:"US09061G1013";s:3:"WKN";s:6:"924801";s:16:"ShortDescription";s:8:"BIOMARIN";s:13:"AbsoluteValue";d:47.93;s:13:"RelativeValue";d:0.0020380488835238107;s:12:"AbsoluteGain";d:-43.148048780488;s:12:"RelativeGain";d:-0.47374805848642393;s:8:"Quantity";d:1;}i:31;a:8:{s:4:"ISIN";s:12:"US1101221083";s:3:"WKN";s:6:"850501";s:16:"ShortDescription";s:25:"BRISTOL-MYERS SQUIBBDL-10";s:13:"AbsoluteValue";d:3771.2;s:13:"RelativeValue";d:0.1603565605997287;s:12:"AbsoluteGain";d:30.8;s:12:"RelativeGain";d:0.008234413431718534;s:8:"Quantity";d:80;}i:32;a:8:{s:4:"ISIN";s:12:"US09075V1026";s:3:"WKN";s:6:"A2PSR2";s:16:"ShortDescription";s:24:"BIONTECH SE SPON. ADRS 1";s:13:"AbsoluteValue";d:3142;s:13:"RelativeValue";d:0.13360211959173407;s:12:"AbsoluteGain";d:-191.6;s:12:"RelativeGain";d:-0.05747540196784257;s:8:"Quantity";d:40;}i:33;a:8:{s:4:"ISIN";s:12:"US0042251084";s:3:"WKN";s:6:"603035";s:16:"ShortDescription";s:25:"ACADIA PHARMACEUT. DL-,01";s:13:"AbsoluteValue";d:18.745;s:13:"RelativeValue";d:0.0007970629318100112;s:12:"AbsoluteGain";d:-19.836;s:12:"RelativeGain";d:-0.5141390840050802;s:8:"Quantity";d:1;}i:34;a:8:{s:4:"ISIN";s:12:"US02043Q1076";s:3:"WKN";s:6:"A0CBCK";s:16:"ShortDescription";s:25:"ALNYLAM PHARMACE.DL-,0001";s:13:"AbsoluteValue";d:241.6;s:13:"RelativeValue";d:0.010273161073635568;s:12:"AbsoluteGain";d:153.518;s:12:"RelativeGain";d:1.7428986626098408;s:8:"Quantity";d:1;}i:35;a:8:{s:4:"ISIN";s:12:"US00847X1046";s:3:"WKN";s:6:"A1W2RM";s:16:"ShortDescription";s:25:"AGIOS PHARMACEUT. DL-,001";s:13:"AbsoluteValue";d:3700;s:13:"RelativeValue";d:0.1573290396210745;s:12:"AbsoluteGain";d:-1700.5;s:12:"RelativeGain";d:-0.31487825201370245;s:8:"Quantity";d:125;}}" ] ] "licence_switzerland" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf1m" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf12m" => array:1 [ 0 => array:1 [ "value" => "7.14993" ] ] "perfever" => array:1 [ 0 => array:1 [ "value" => "-28.0296" ] ] "aum" => array:1 [ 0 => array:1 [ "value" => "1439.41" ] ] "topwikis" => array:1 [ 0 => array:1 [ "value" => "8333" ] ] "created" => array:1 [ 0 => array:1 [ "value" => "1649766873" ] ] "changed" => array:1 [ 0 => array:1 [ "value" => "1781990684" ] ] "solid_valor" => array:1 [ 0 => array:1 [ "value" => "28282105" ] ] "solid_bc" => array:1 [ 0 => array:1 [ "value" => "LSD" ] ] "solid_bc_id" => array:1 [ 0 => array:1 [ "value" => "2913" ] ] "solid_cc" => array:1 [ 0 => array:1 [ "value" => "EUR" ] ] "solid_cc_id" => array:1 [ 0 => array:1 [ "value" => "814" ] ] "fullquote_link" => array:1 [ 0 => array:1 [ "value" => "wikifolio/wf0biphage-lgsz-zt-28282105/lsd/eur" ] ] "solid_changed" => array:1 [ 0 => array:1 [ "value" => "1661258840" ] ] ]